RETRACTED ARTICLE: A two-pronged attack on antibiotic-resistant microbes

Mehellou, Youcef; Willcox, Benjamin E.

doi:10.1038/d41586-020-03660-z

NEWS AND VIEWS
11 January 2021
Retraction 27 September 2021

RETRACTED ARTICLE: A two-pronged attack on antibiotic-resistant microbes

Isoprenoid molecules are essential in many disease-causing microorganisms, and intermediates made during their synthesis trigger immune-defence responses by γδ T cells. ‘Immunoantibiotics’ exploit this dual vulnerability.

Youcef Mehellou⁰ &
Benjamin E. Willcox¹

Youcef Mehellou
1. Youcef Mehellou is in the School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, UK.
View author publications

You can also search for this author in PubMed Google Scholar
Benjamin E. Willcox
1. Benjamin E. Willcox is at the Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
View author publications

You can also search for this author in PubMed Google Scholar

Access through your institution

Buy or subscribe

The emergence of strains of harmful microorganisms that are resistant to antibiotic treatment is a major global health concern. This has prompted ongoing drug-development efforts, including the identification of possible biological targets linked to essential microbial processes. However, the clinical development of drugs is slow, and the emergence of resistance to newly developed compounds remains a continuing problem. Finding alternative ways to tackle the emergence of antibiotic-resistant bacteria is of paramount importance. Writing in Nature, Singh et al.¹ outline a two-pronged strategy to address this challenge.

Access options

Access through your institution

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 589, 517-518 (2021)

doi: https://doi.org/10.1038/d41586-020-03660-z

Updates & Corrections

Retraction 27 September 2021: In view of the fact that the authors of the article ‘IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance’ (K. S. Singh et al. Nature 589, 597–602; 2021) are retracting their report, the authors of this News & Views wish to retract their article, which dealt with this study and was based on the accuracy and reproducibility of the data in the study.

References

Singh, K. S. et al. Nature 589, 597–602 (2021).
Article Google Scholar
Zhao, L., Chang, W.-C., Xiao, Y., Liu, H. W. & Liu, P. Annu. Rev. Biochem. 82, 497–530 (2013).
Article PubMed Google Scholar
Janthawornpong, K. et al. J. Am. Chem. Soc. 135, 1816–1822 (2013).
Article PubMed Google Scholar
Jomaa, H. et al. Science 285, 1573–1576 (1999).
Article PubMed Google Scholar
McAteer, S., Coulson, A., McLennan, N. & Masters, M. J. Bacteriol. 183, 7403–7407 (2001).
Article PubMed Google Scholar
Wang, K. et al. J. Am. Chem. Soc. 132, 6719–6727 (2010).
Article PubMed Google Scholar
Zinglé, C., Kuntz, L., Tritsch, D., Grosdemange-Billiard, C. & Rohmer, M. J. Org. Chem. 75, 3203–3207 (2010).
Article PubMed Google Scholar
Morita, C. T., Jin, C., Sarikonda, G. & Wang, H. Immunol. Rev. 215, 59–76 (2007).
Article PubMed Google Scholar
Willcox, C. R., Mohammed, F. & Willcox, B. E. Immunol. Rev. 298, 25–46 (2020).
Article PubMed Google Scholar
Silva-Santos, B., Mensurado, S. & Coffelt, S. B. Nature Rev. Cancer 19, 392–404 (2019).
Article PubMed Google Scholar